Growth Metrics

Core Laboratories (CLB) Total Non-Current Liabilities (2022 - 2026)

Core Laboratories filings provide 5 years of Total Non-Current Liabilities readings, the most recent being $303.0 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 2.68% to $303.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $303.0 million, a 2.68% decrease, with the full-year FY2025 number at $302.2 million, down 3.17% from a year prior.
  • Total Non-Current Liabilities hit $303.0 million in Q1 2026 for Core Laboratories, roughly flat from $302.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $373.9 million in Q4 2022 to a low of $292.5 million in Q3 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $323.8 million (2024), compared with a mean of $327.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: dropped 9.66% in 2025 and later decreased 2.68% in 2026.
  • Core Laboratories' Total Non-Current Liabilities stood at $373.9 million in 2022, then dropped by 8.55% to $342.0 million in 2023, then dropped by 8.74% to $312.1 million in 2024, then decreased by 3.17% to $302.2 million in 2025, then increased by 0.26% to $303.0 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $303.0 million (Q1 2026), $302.2 million (Q4 2025), and $292.5 million (Q3 2025) per Business Quant data.